RxDoctor Payments DataLook up a doctor →

Timothy Schoonover, DO

Neurology · Centerville, OHNPI 1033111802

Payments from drug & device makers

$610,953in general payments, 2019–2025

Across 1,623 payments — averaging $376.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$232K
  • Amgen$105K
  • Eli Lilly$94K
  • Novartis$63K
  • Teva Pharmaceuticals USA, Inc.$47K
  • Regeneron$24K
  • plus $45K from 54 others
$5,252in research payments, 2019–2025

Across 2 payments — averaging $2626.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$5K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)446$231,916
Amgen(2 entities)156$104,780
Eli Lilly9$93,949
Novartis113$63,461
Teva Pharmaceuticals USA, Inc.171$47,325
Regeneron22$24,214
UCB SA2$22,798
Biogen42$9,678
UCB, Inc.53$1,016
AstraZeneca(2 entities)34$887
EMD Serono, Inc.36$867
Lilly USA, LLC53$661
Pfizer41$646
Neurocrine Biosciences, Inc.38$544
Eisai Inc.20$511
Supernus Pharmaceuticals, Inc.35$488
Sanofi25$467
MDD US Operations, LLC26$452
SK Life Science, Inc.22$449
Amneal Pharmaceuticals LLC23$419
Acadia Pharmaceuticals Inc21$393
Genentech USA, Inc.16$364
Biohaven Pharmaceutical Holding Company Ltd.18$351
Biohaven Pharmaceuticals, Inc.11$312
Lundbeck LLC12$312
Acorda Therapeutics, Inc18$273
Johnson & Johnson11$261
Jazz Pharmaceuticals Inc.11$235
Insightec,inc5$231
Argenx US, Inc.10$228
Sunovion Pharmaceuticals Inc.10$167
Takeda Pharmaceuticals U.S.A., Inc.6$163
Hyperfine Operations, Inc.1$156
Ipsen Biopharmaceuticals, Inc9$132
Alnylam Pharmaceuticals Inc.7$132
Abbott1$129
Merz Pharmaceuticals, LLC6$120
Greenwich Biosciences, Inc.8$118
Kyowa Kirin, Inc.5$106
Neurelis, Inc.6$102
Adamas Pharmaceuticals, Inc.7$98
Avanir Pharmaceuticals, Inc.5$96
GE HealthCare3$95
TG Therapeutics, Inc.4$78
CSL Behring5$69
Grifols USA, LLC4$69
Sumitomo Pharma America, Inc.3$66
Harmony Biosciences LLC3$62
Octapharma USA, Inc.4$59
Revance Therapeutics, Inc.2$48
Portola Pharmaceuticals, LLC3$37
Amylyx Pharmaceuticals, Inc.2$36
Axsome Therapeutics, Inc.2$33
Currax Pharmaceuticals LLC2$32
Merz North America, Inc.2$32
Tanabe Pharma America, Inc.2$32
Boston Scientific1$26
Sandoz1$26
Averitas Pharma Inc.1$25
Philips North America LLC1$22

How this compares

$610,953 in reported general payments places this provider in the 90th percentile of 702 neurology providers in Ohio.

See all neurology providers in Ohio →

Medicare billing

Part B allowed, 2024
$517,606
Medicare patients
230
Services billed
68,900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Centerville

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →